Sarah James
Stock Analyst at Cantor Fitzgerald
(1.94)
# 3,084
Out of 5,182 analysts
309
Total ratings
31.88%
Success rate
-8.1%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $3.56 | +209.42% | 1 | Mar 23, 2026 | |
| DCGO DocGo | Reiterates: Overweight | $3 | $0.57 | +426.32% | 9 | Mar 17, 2026 | |
| HCAT Health Catalyst | Maintains: Neutral | $4 → $3 | $1.17 | +156.41% | 9 | Mar 13, 2026 | |
| UHS Universal Health Services | Maintains: Neutral | $250 → $229 | $176.70 | +29.60% | 28 | Feb 27, 2026 | |
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $3.92 | +104.08% | 1 | Feb 17, 2026 | |
| HUM Humana | Maintains: Neutral | $290 → $201 | $177.83 | +13.03% | 22 | Feb 12, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $180 → $144 | $139.38 | +3.31% | 15 | Feb 9, 2026 | |
| CNC Centene | Reiterates: Neutral | $41 | $35.11 | +16.78% | 17 | Feb 9, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $471.84 | +24.62% | 22 | Jan 28, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $23.96 | -29.05% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $95 | $73.49 | +29.27% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $245 | $188.17 | +30.20% | 23 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $36 | $12.18 | +195.57% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $277.26 | +58.70% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $270.02 | +35.18% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $16.60 | +68.67% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $300.74 | +61.27% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $16.24 | +78.57% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.51 | +327.35% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $5.27 | +89.75% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $145.58 | -8.64% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $22.20 | +89.23% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $7.61 | -34.30% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $6.38 | -21.63% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $18.76 | +11.94% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $54.79 | -28.82% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $73.94 | +161.02% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.96 | - | 2 | Mar 1, 2017 |
Nyxoah
Mar 23, 2026
Reiterates: Overweight
Price Target: $11
Current: $3.56
Upside: +209.42%
DocGo
Mar 17, 2026
Reiterates: Overweight
Price Target: $3
Current: $0.57
Upside: +426.32%
Health Catalyst
Mar 13, 2026
Maintains: Neutral
Price Target: $4 → $3
Current: $1.17
Upside: +156.41%
Universal Health Services
Feb 27, 2026
Maintains: Neutral
Price Target: $250 → $229
Current: $176.70
Upside: +29.60%
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $3.92
Upside: +104.08%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $177.83
Upside: +13.03%
Molina Healthcare
Feb 9, 2026
Maintains: Neutral
Price Target: $180 → $144
Current: $139.38
Upside: +3.31%
Centene
Feb 9, 2026
Reiterates: Neutral
Price Target: $41
Current: $35.11
Upside: +16.78%
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $471.84
Upside: +24.62%
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $23.96
Upside: -29.05%
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $73.49
Upside: +29.27%
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $188.17
Upside: +30.20%
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $12.18
Upside: +195.57%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $277.26
Upside: +58.70%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $270.02
Upside: +35.18%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $16.60
Upside: +68.67%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $300.74
Upside: +61.27%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $16.24
Upside: +78.57%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.51
Upside: +327.35%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.27
Upside: +89.75%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $145.58
Upside: -8.64%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $22.20
Upside: +89.23%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $7.61
Upside: -34.30%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $6.38
Upside: -21.63%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $18.76
Upside: +11.94%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $54.79
Upside: -28.82%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $73.94
Upside: +161.02%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.96
Upside: -